Opinion|Videos|August 1, 2024
Future Possibilities in IPF Treatment
Author(s)Steven D. Nathan, MD
Dr Nathan discusses the trajectory of IPF management.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you envision these investigational agents potentially being implemented into future treatment paradigms for idiopathic pulmonary fibrosis (IPF)?
- Cell-based therapies represent another modality being explored for IPF. What is the potential impact of this type of treatment?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention
5
